|
Market Closed -
Nasdaq Stockholm
19:35:00 10/07/2026 +04
|
5-day change
|
1st Jan Change
|
|
3,177.78 PTS
|
-0.27%
|
|
-2.13%
|
+10.23%
|
|
07-10 |
Handelsbanken expected to report SEK 6,987m in operating profit - Modular
|
FW
| |
07-10 |
Keefe, Bruyette & Woods raises Swedbank price target to 330 kronor (315), reiterates underperform - BN
|
FW
| |
07-10 |
Keefe, Bruyette & Woods raises target price for SEB to 190 kronor (185), reiterates underperform - BN
|
FW
| |
07-10 |
ABG Sundal Collier Downgrades ABB to Hold, Raises PT
|
MT
| |
07-10 |
Carnegie Strategifond rose 1.41 percent in June, geopolitical concerns eased somewhat
|
FW
| |
07-10 |
Addtech expected to report SEK 998m in EBITA - FactSet
|
FW
| |
07-10 |
Telia expected to report SEK 8,339m in adjusted EBITDA - Modular
|
FW
| |
07-10 |
AstraZeneca: An unexpected late-stage failure doesn't derail Astra
|  | |
07-10 |
Indecap Sverige rose 2.0 percent in June, Alfa Laval and Atlas Copco among the top contributors
|
FW
| |
07-10 |
Kepler upgrades Epiroc to buy, raises forecasts
|
FW
| |
07-10 |
Kepler Cheuvreux raises Epiroc to buy (hold), target price 300 kronor (245)
|
FW
| |
07-10 |
SEB expected to report operating profit of SEK 9,711m - Factset
|
FW
| |
07-10 |
Lifco expected to report 1,725 million kronor in adjusted EBITA, FactSet
|
FW
| |
07-10 |
Handelsbanken cuts Industrivarden to Hold
|
FW
| |
07-10 |
Handelsbanken downgrades Industrivarden to hold (buy), target price 570 kronor (545)
|
FW
| |
07-10 |
EQT to buy AI infrastructure company Copia Power
|
FW
| |
07-10 |
US Appeals Court Upholds Ruling in Favor of AstraZeneca in Patent Case Against Pfizer Unit
|
MT
| |
07-10 |
EQT to Buy US Energy, AI Infrastructure Development Platform from Carlyle
|
MT
| |
07-10 |
Health Care Down on Rotation Out of Defensive Sectors - Health Care Roundup
|
DJ
| |
07-09 |
AstraZeneca Wins Pfizer Patent Battle Over Cancer Drug
|
MT
| |
07-09 |
AstraZeneca Wins Pfizer Patent Battle Over Cancer Drug
|
MT
| |
07-09 |
Top Midday Decliners
|
MT
| |
07-09 |
AstraZeneca's Rare Drug Trial Failure Sends Shares Plunging
|
MT
| |
07-09 |
Ericsson is expected to report 6.8bn kronor in adjusted EBITA, Bloomberg
|
FW
| |
07-09 |
Tele2 Obtains New Spectrum Bands in Lithuania, Renews Existing License
|
MT
| |
07-09 |
Tele2 invests nearly 10m in Lithuanian spectrum
|
FW
| |
07-09 |
Tele2 secures new spectrum in Lithuania
|
FW
| |
07-09 |
Acadian Asset Management is a new public short seller in SCA
|
FW
| |
07-09 |
BofA Notes AstraZeneca's 'Surprise' Wainua Late-stage Trial Miss; Buy Rating Retained
|
MT
| |
07-09 |
EU approves Gotlandsbolaget's deal with EQT-owned Nordic Ferry Infrastructure
|
FW
| |
07-09 |
Lannebo Sverige Fokus rose 1.9% in June, Alfa Laval, SOBI and AstraZeneca contributed the most
|
FW
| |
07-09 |
AstraZeneca Shares Slide After Wainua Treatment Fails Heart Disease Trial
|
DJ
| |
07-09 |
BofA cuts H&M price target
|
FW
| |
07-09 |
Bank of America lowers its target price for H&M to 145 kronor (150), reiterates underperform
|
FW
| |
07-09 |
AstraZeneca Shares Slide After Heart Drug Trial Misses Primary Endpoint
|
MT
| |
07-09 |
Ionis, AstraZeneca Report Amyloid Cardiomyopathy Treatment Failed to Meet Primary Endpoint in Phase 3
|
MT
| |
07-09 |
AstraZeneca shares slump after clinical trial fails
|  | |
07-09 |
AstraZeneca shares fall 9% as cardiovascular drug Wainua fails test
|
AN
| |
07-09 |
H&M's CFO buys shares for SEK0.8m
|
FW
| |
07-09 |
Handelsbanken cuts SCA target price ahead of earnings report, reiterates buy
|
FW
|
No results match your criteria
Highest OMX Stockholm 30 Index increases
|
|
|
|
+2.73%
|
|
|
+1.27%
|
|
|
+1.17%
|
|
|
+1.12%
|
|
|
+0.99%
|
The sharpest declines in OMX Stockholm 30 Index.
|
|
|
|
-1.27%
|
|
|
-1.30%
|
|
|
-1.91%
|
|
|
-3.10%
|
|
|
-3.89%
|
Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
|